Hedgehog signaling drives medulloblastoma growth via CDK6-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hedgehog signaling drives medulloblastoma growth via CDK6

Published:2017-11-20 Issue:1 Volume:128 Page:120-124
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Raleigh David R.,Choksi Pervinder K.,Krup Alexis Leigh,Mayer Wasima,Santos Nicole,Reiter Jeremy F.

Funder

NIH Clinical Center

Burroughs Wellcome Fund

David and Lucile Packard Foundation

V Foundation for Cancer Research

American Society of Clinical Oncology

Rally Foundation

American Brain Tumor Association

National Institutes of Health

UCSF Physician Scientist Scholar Program

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/92710/files/pdf

Reference25 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2008-2012;Ostrom;Neuro-oncology,2015

2. Medulloblastomics: the end of the beginning

3. The mechanisms of Hedgehog signalling and its roles in development and disease;Briscoe;Nat Rev Mol Cell Biol,2013

4. Acquisition of Granule Neuron Precursor Identity Is a Critical Determinant of Progenitor Cell Competence to Form Shh-Induced Medulloblastoma

5. Dual and opposing roles of primary cilia in medulloblastoma development

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights into medulloblastoma relapse;Pharmacology & Therapeutics;2024-08

2. Targeting Super-Enhancer–Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance;Cancer Research;2024-05-22

3. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics;Current Pharmaceutical Design;2024-01

4. Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies;Pharmacology & Therapeutics;2023-10

5. hGFAP-mediated GLI2 overexpression leads to early death and severe cerebellar malformations with rare tumor formation;iScience;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3